[1]Massart R，Barnea R，Dikshtein Y，et al. Role of DNA methylation in the nucleus accumbens in incubation of cocaine craving［J］. J Neurosci，2015，35(21)：8042-8058.
[2]Chen H，Yu Y，Rong S，et al. Evaluation of diagnostic accuracy of DNA methylation biomarkers for bladder cancer：A systematic review and Meta-analysis［J］.Biomarkers，2014，19(3)：189-197.
[3]Geradts J，Wilentz RE，Roberts H.Immunohistochemical detection of the alternate INK4a-encoded tumor suppressor protein p14(ARF) in archival human cancers and cell lines using commercial antibodies：Correlation with p16(INK4a) expression［J］.Mod Pathol，2001，14(11)：1162-1168.
[4]Esteller M，Cordon-Cardo C，Corn PG，et al. p14ARF silencing by promoter hypermethylation mediatesabnormal intracellular localization of MDM2［J］. Cancer Res，2001，61(7)：2816-2821.
[5]Qiao D，Gaitonde SV，Qi Wei，et al.Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation［J］. Carcinogenesis，2001，22(6)：957-964.
[6]Damia G，Filiberti L，Vikhanskaya F，et al.Cisplatinum and taxol induce different patterns of p53 phosphorylation［J］. Neoplasia，2001，3(1)：10-16.
[7]Pu X，Zhu L，Fu Y，et al.Companied p16 genetic and protein status together providing useful information on the clinical outcome of urinary bladder cancer［J］.Medicine，2018，97(15)：353-361.
[8]Breyer J，Wirtz RM，Erben P，et al.High CDKN2A/p16 and low FGFR3 expression predict progressive potential of stage pT1 urothelial bladder carcinoma［J］.Clin Genitourin Cancer，2018，39(2)：7661-7673.
[9]Da Silva JNL，Ranzi AD，Carvalho，et al.CT cell cycle markers in the evaluation of bladder cancer［J］.Pathol Oncol Res，2018，25(3)：143-150.
[10]Owczarek TB，Kobayashi T，Ramirez R，et al.ARF confers a context-dependent response to chemotherapy in muscle-invasive bladder cancer［J］.Cancer Res，2017，77(4)：1035-1046.
[11]Burri N，Shaw P，Bouzourene H，et al. Methylation silencing and mutations of the p14ARF and p16INK4A genes in colon cance［J］. Lab Invest，2001，81(3)：217-229.
[12]Tortora G，Caputo R，Damiano V，et al.A novel MDM2 anti-sense oligonucleotide has anti-tumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancer［J］. Int J Cancer，2000，88(5)：804-809.
[13]Veloso M，Wrba F，Kaserer K，et al. p53 gene status and expression of p53，MDM2，and p21Waf1/Cip1 proteins in colorectal cancer［J］. Virchows Arch，2000，437(3)：241-247.
[14]Li Jianping，Zhang Xiaoqing，Zuo Keqiang，et al.Relationship between p16 protein expression and mutation in nasopharyngeal carcinoma(NPC)［J］.China Journal of Modern Medicine，2005，15(10)：1457-1460.［李建萍，张小清，左克强，等.鼻咽癌 p16 基因表达与突变的对比研究及意义［J］.中国现代医学杂志，2005，15(10)：1457-1460.］
[15]Wei Guohua，Yang Chunyu，Yang Jing，et al.Aberrant methylation of p16 gene in gastric carcinoma and its precancerous lesions［J］.China Journal of Modern Medicine，2010，20(10)：1490-1493.［魏国华，杨春雨，杨静，等.胃癌及癌前病变中 p16 基因启动子异常甲基化研究［J］.中国现代医学杂志，2010，20(10)：1490-1493.］
[16]Wang Wenpu，Zhang Aili，Liu Lianghong，et al.Expression and significance of p16 and ezrin in cervical squamous cell carcinoma［J］.China Journal of Modern Medicine，2012，22(27)：23-27.［王文普，张爱丽，刘亮洪，等. p16 和 Ezrin 在宫颈鳞状细胞癌中的表达及意义［J］.中国现代医学杂志，2012，22(27)：23-27.］
[17]Zhang Gang，Sun Yinghao，Zhang Shaozeng，et al.The expression of p16 and nm-23H1 genes protein in bladder carcinoma and clinical significance［J］.J Lanzhou Med Coll，2002，28(4)：29-31.［张钢，孙颖浩，张绍增，等. p16、nm23-H1基因蛋白在膀胱癌的表达与临床意义［J］. 兰州医学院学报,2002，28(4)：29-31.］
[18]Zeng Guqing，Kang Ying，Gao Tianshu，et al.Relationship between expression of p16 protein and cell proliferation in breast cancer tissue［J］.China Journal of Modern Medicine，2007，17(6)：650-653.［曾谷清，康颖，高天舒，等.乳腺癌组织中p16蛋白的表达与细胞增殖的关系［J］.中国现代医学杂志，2007，17(6)：650-653.］